Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma

Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma

<p>Abstract</p> <p>Background</p> <p>Although numerous chemotherapeutic agents have been tested, the role of systemic chemotherapy for hepatocellular carcinoma (HCC) has not been clarified. New therapeutic strategies are thus needed to improve outcomes, and we designed...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Bang Soo-Mee, Lee Jeong, Park Yeon, Kim Ju, Kim Sun, Kwon Oh, Kwon So, Han Sang, Lee Yuna, Park Se, Cho Eun, Shin Dong, Lee Jae
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	BMC 2006-01-01
Reeks:	BMC Cancer
Online toegang:	http://www.biomedcentral.com/1471-2407/6/3

Gelijkaardige items

Capecitabine and cisplatin (XP) combination systemic chemotherapy in heavily pre-treated HER2 negative metastatic breast cancer.
door: Jieun Lee, et al.
Gepubliceerd in: (2017-01-01)

Metronomic capecitabine versus doxorubicin in advanced hepatocellular carcinoma
door: Gehan Abd Elatti Khedr, et al.
Gepubliceerd in: (2016-06-01)

Docetaxel plus cisplatin is effective for patients with metastatic breast cancer resistant to previous anthracycline treatment: a phase II clinical trial
door: Lee Jae, et al.
Gepubliceerd in: (2005-02-01)

Intra-Arterial Chemotherapy with Doxorubicin and Cisplatin Is Effective for Advanced Hepatocellular Cell Carcinoma
door: Ming-Chun Ma, et al.
Gepubliceerd in: (2014-01-01)

Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE)
door: Min‐Hee Ryu, et al.
Gepubliceerd in: (2023-04-01)

Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancer
door: Kim Hyeong, et al.
Gepubliceerd in: (2010-10-01)

Chemotherapy for Metastatic Gastric Cancer
door: Sung Eun Kim, et al.
Gepubliceerd in: (2025-01-01)

Acute Aortic Thrombosis Following Capecitabine Chemotherapy in a Patient with Colon Cancer
door: Min Kyung Lee, et al.
Gepubliceerd in: (2018-09-01)

Lymphocyte-monocyte ratio at day 14 of first cisplatin-doxorubicin chemotherapy is associated with treatment outcome of pediatric patients with localized osteosarcoma
door: Jun Ah Lee, et al.
Gepubliceerd in: (2019-02-01)

Prolonged Endurance Exercise Adaptations Counteract Doxorubicin Chemotherapy-Induced Myotoxicity in Mice
door: Insu Kwon, et al.
Gepubliceerd in: (2022-04-01)

Capecitabine Maintenance Chemotherapy in the Treatment of Metastatic Colorectal Cancer: A Meta-Analysis
door: Bradley Ashley Gue Ong, et al.
Gepubliceerd in: (2022-04-01)

Identification of a biomarker to predict doxorubicin/cisplatin chemotherapy efficacy in osteosarcoma patients using primary, recurrent and metastatic specimens
door: Qiong Ma, et al.
Gepubliceerd in: (2024-11-01)

The results of primary chemotherapy of TS-1/cisplatin regimen in unresectable or metastatic gastric cancer patients
door: Jung Hyun Song, et al.
Gepubliceerd in: (2014-06-01)

Olaratumab and doxorubicin for the treatment of metastatic soft tissue sarcoma: a retrospective case series
door: Joon Young Hur, et al.
Gepubliceerd in: (2019-06-01)

Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder
door: Hyun Hwan Sung, et al.
Gepubliceerd in: (2022-03-01)

gene amplification in patients with metastatic cancer
door: Su Jin Lee, et al.
Gepubliceerd in: (2017-09-01)

Real-world efficacy and safety of capecitabine with oxaliplatin in patients with advanced adenocarcinoma of the ampulla of Vater
door: Seunghwan Lee, et al.
Gepubliceerd in: (2024-05-01)

Occupational Exposure during Intraperitoneal Pressurized Aerosol Chemotherapy Using Doxorubicin in a Pig Model
door: Wongeon Jung, et al.
Gepubliceerd in: (2023-06-01)

Neoadjuvant Bevacizumab Plus Docetaxel/Cisplatin/Capecitabine Chemotherapy in Locally Advanced Gastric Cancer Patients: A Pilot Study
door: Deguo Yu, et al.
Gepubliceerd in: (2022-05-01)

Switching cisplatin to carboplatin in chemotherapy for metastatic penile cancer in a patient intolerant to cisplatin
door: Keita Sekine, et al.
Gepubliceerd in: (2024-11-01)

Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage
door: Kabsoo Shin, et al.
Gepubliceerd in: (2019-12-01)

Capecitabine and temozolomide for metastatic intermediate to high-grade pancreatic neuroendocrine neoplasm: a single center experience
door: Sathathone Douangprachanh, et al.
Gepubliceerd in: (2022-11-01)

Maintenance chemotherapy after 6 cycles of platinum-doublet regimen in anthracycline-and taxane-pretreated metastatic breast cancer
door: Eun Kyo Joung, et al.
Gepubliceerd in: (2021-01-01)

Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effects
door: Ying Gao, et al.
Gepubliceerd in: (2021-09-01)

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy
door: Kim Dong-Wan, et al.
Gepubliceerd in: (2007-04-01)

Oral Capecitabine Achieves Response in Metastatic Eccrine Carcinoma
door: Kristian Larson, et al.
Gepubliceerd in: (2018-01-01)

Assessing the Percent of Necrosis after Neoadjuvant Chemotherapy with 24hr Infusional Cisplatin/3 Days Doxorubicin Intermittent with IfosfamideDoxorubicin for Osteosarcoma
door: Mozhgan Aalam Samimi, et al.
Gepubliceerd in: (2014-03-01)

Gemcitabine–cisplatin versus MVAC chemotherapy for urothelial carcinoma: a nationwide cohort study
door: Yong Seong Lee, et al.
Gepubliceerd in: (2023-03-01)

Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study
door: Satoru Iwasa, et al.
Gepubliceerd in: (2023-04-01)

Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study.
door: In Sil Choi, et al.
Gepubliceerd in: (2018-01-01)

Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasis from pancreatic adenocarcinoma and cholangiocarcinoma
door: Andrea Di Giorgio, et al.
Gepubliceerd in: (2020-07-01)

CAPECITABINE IN THE TREATMENT OF BRAIN METASTATIC LESION IN PATIENTS WITH BREAST CANCER
door: E. A. Moskvina, et al.
Gepubliceerd in: (2015-04-01)

Real-world outcomes of adjuvant gemcitabine gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma
door: Sora Kang, et al.
Gepubliceerd in: (2022-05-01)

Complex interaction networks of cytokines after transarterial chemotherapy in patients with hepatocellular carcinoma.
door: Dong Wook Jekarl, et al.
Gepubliceerd in: (2019-01-01)

Endostar Combined with Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Nasopharyngeal Carcinoma: an Update
door: Ting Jin, et al.
Gepubliceerd in: (2018-04-01)

Cisplatin and vinorelbine in the treatment of locally advanced and metastatic non-small cell lung cancer
door: Wong, Catherine Mee Ming, et al.
Gepubliceerd in: (2001)

Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy
door: Kwang Hyun Chung, et al.
Gepubliceerd in: (2017-03-01)

Economic evaluation of third-line neratinib plus capecitabine versus lapatinib plus capecitabine with HER2+ metastatic breast cancer
door: Lanqi Ren, et al.
Gepubliceerd in: (2023-08-01)

Milnacipran Has an Antihyperalgesic Effect on Cisplatin-Induced Neuropathy
door: Sun Jin Cho, et al.
Gepubliceerd in: (2023-08-01)

Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
door: Kim Mi-Jung, et al.
Gepubliceerd in: (2012-08-01)